Hits, Fhits and Nits: Beyond enzymatic function

Advances in Enzyme Regulation

Volumn 51, Issue 1, 2011, Pages 208-217

  Huebner, Kay ^a   Saldivar, Joshua C ^a   Sun, Jin ^a   Shibata, Hidetaka ^a   Druck, Teresa ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID ANHYDRIDE HYDROLASE; FRAGILE HISTIDINE TRIAD PROTEIN; HISTIDINE TRIAD PROTEIN; HYDROLASE; NITRILASE; TUMOR PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; REVIEW; SEQUENCE ALIGNMENT;

ACID ANHYDRIDE HYDROLASES; AMINO ACID SEQUENCE; AMINOHYDROLASES; ANIMALS; HUMANS; HYDROLASES; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; SEQUENCE ALIGNMENT;

EID: 79954458878     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2010.09.003     Document Type: Review

References (50)

1. Barglow K.T., Saikatendu K.S., Bracey M.H., Huey R., Morris G.M., Olson A.J., et al. Functional proteomic and structural insights into molecular recognition in the nitrilase family enzymes. Biochemistry 2008, 47:13514-13523.
2. Barnes L.D., Garrison P.N., Siprashvili Z., Guranowski A., Robinson A.K., Ingram S.W., et al. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5,5-P1, P3-triphosphate hydrolase. Biochemistry 1996, 35:11529-11535.
3. Bieganowski P., Garrison P.N., Hodawadekar S.C., Faye G., Barnes L.D., Brenner C. Adenosine monophosphoramidase activity of Hint and Hnt1 supports function of Kin28, Ccl1, and Tfb3. J Biol Chem 2002, 277:10852-10860.
4. Brenner C. Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. Biochemistry 2002, 41:9003-9014.
5. Brenner C., Bieganowski P., Pace H.C., Huebner K. The histidine triad superfamily of nucleotide-binding proteins. J Cell Physiol 1999, 181:179-187.
6. Cen B., Li H., Weinstein I.B. Histidine triad nucleotide-binding protein 1 up-regulates cellular levels of p27KIP1 by targeting ScfSKP2 ubiquitin ligase and Src. J Biol Chem 2009, 284:5265-5276.
7. Chaudhuri A.R., Khan I.A., Prasad V., Robinson A.K., Ludueña R.F., Barnes L.D. The tumor suppressor protein Fhit. A novel interaction with tubulin. J Biol Chem 1999, 274:24378-24382.
8. Chou T.F., Baraniak J., Kaczmarek R., Zhou X., Cheng J., Ghosh B., et al. Phosphoramidate pronucleotides: a comparison of the phosphoramidase substrate specificity of human and Escherichia coli histidine triad nucleotide binding proteins. Mol Pharm 2007, 4:208-217.
9. Date H., Onodera O., Tanaka H., Iwabuchi K., Uekawa K., Igarashi S., et al. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat Genet 2001, 29:184-188.
10. Durkin S.G., Ragland R.L., Arlt M.F., Mulle J.G., Warren S.T., Glover T.W. Replication stress induces tumor-like microdeletions in FHIT/FRA3B. Proc Natl Acad Sci USA 2008, 105:246-251.
11. Fong L.Y., Fidanza V., Zanesi N., Lock L.F., Siracusa L.D., Mancini R., et al. Muir-Torre-like syndrome in Fhit-deficient mice. Proc Natl Acad Sci USA 2000, 97:4742-4747.
12. Hu B., Han S., Wang X., Ottey M., Dicker A., Huebner K., et al. Involvement of the Fhit gene in the ionizing radiation-activated ATR/CHK1 pathway. J Cell Physiol 2005, 202:518-523.
13. Huang Y., Garrison P.N., Barnes L.D. Cloning of the Schizosaccharomyces pombe gene encoding diadenosine 5',5‴-P1, P4-tetraphosphate (Ap4A) asymmetrical hydrolase: sequence similarity with the histidine triad (HIT) protein family. Biochem J 1995, 312:925-932.
14. Huebner K., Garrison P.N., Barnes L.D., Croce C.M. The role of the FHIT/FRA3B locus in cancer. Annu Rev Genet 1998, 32:7-31. Review.
15. Ingram S.W., Barnes L.D. Disruption and overexpression of the Schizosaccharomyces pombe aph1 gene and the effects on intracellular diadenosine 5',5″-P1, P4-tetraphosphate (Ap4A), ATP and ADP concentrations. Biochem J 2000, 350:663-669.
16. Ishii H., Dumon K.R., Vecchione A., Fong L.Y., Baffa R., Huebner K., et al. Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies. JAMA 2001, 286:2441-2449. Review.
17. Ishii H., Mimori K., Inoue H., Inageta T., Ishikawa K., Semba S., et al. Fhit modulates the DNA damage checkpoint response. Cancer Res 2006, 66:11287-11292.
18. Ishii H., Wang Y., Huebner K.A. Fhit-ing role in the DNA damage checkpoint response. Cell Cycle 2007, 6:1044-1048.
19. Jaisson S., Veiga-da-Cunha M., Van Schaftingen E. Molecular identification of omega-amidase, the enzyme that is functionally coupled with glutamine transaminases, as the putative tumor suppressor Nit2. Biochimie 2009, 91:1066-1071.
20. Jiang Y., Lucas I., Young D.J., Davis E.M., Karrison T., Rest J.S., et al. Common fragile sites are characterized by histone hypoacetylation. Hum Mol Genet 2009, 18:4501-4512.
21. Kijas A.W., Harris J.L., Harris J.M., Lavin M.F. Aprataxin forms a discrete branch in the HIT (histidine triad) superfamily of proteins with both DNA/RNA binding and nucleotide hydrolase activities. J Biol Chem 2006, 281:13939-13948.
22. Krasnikov B.F., Chien C.H., Nostramo R., Pinto J.T., Nieves E., Callaway M., et al. Assay and purification of omega-amidase/Nit2, a ubiquitously expressed putative tumor suppressor, that catalyzes the deamidation of the alpha-keto acid analogues of glutamine and asparagine. Biochimie 2009, 91:1072-1080.
23. Krasnikov B.F., Nostramo R., Pinto J.T., Cooper A.J. Identification of the putative tumor suppressor Nit2 as omega-amidase, an enzyme. Anal Biochem 2009, 391:144-150.
24. Li H., Zhang Y., Su T., Santella R.M., Weinstein I.B. Hint1 is a haplo-insufficient tumor suppressor in mice. Oncogene 2005, 25:713-721.
25. Li H., Balajee A.S., Su T., Cen B., Hei T.K., Weinstein I.B. The HINT1 tumor suppressor regulates both gamma-H2AX and ATM in response to DNA damage. J Cell Biol 2008, 183:253-265.
26. Lima C.D., Klein M.G., Weinstein I.B., Hendrickson W.A. Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. Proc Natl Acad Sci USA 1996, 93:5357-5362.
27. Martin J., Magnino F., Schmidt K., Piguet A.C., Lee J.S., Semela D., et al. Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma. Gastroenterology 2006, 130:2179-2188.
28. Moreira M.C., Barbot C., Tachi N., Kozuka N., Uchida E., Gibson T., et al. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Genet 2001, 29:189-193.
29. Murphy G.A., Halliday D., McLennan A.G. The Fhit tumor suppressor protein regulates the intracellular concentration of diadenosine triphosphate but not diadenosine tetraphosphate. Cancer Res 2000, 60:2342-2344.
30. Nishizaki M., Sasaki J., Fang B., Atkinson E.N., Minna J.D., Roth J.A., et al. Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells. Cancer Res 2004, 64:5745-5752.
31. Ohta M., Inoue H., Cotticelli M.G., Kastury K., Baffa R., Palazzo J., et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996, 84:587-597.
32. Okumura H., Ishii H., Pichiorri F., Croce C.M., Mori M., Huebner K. Fragile gene product, Fhit, in oxidative and replicative stress responses. Cancer Sci 2009, 100:1145-1150.
33. Pace H.C., Garrison P.N., Robinson A.K., Barnes L.D., Draganescu A., Rosler A., et al. Genetic, biochemical and crystallographic definition of a substrate analog complex with the fragile histidine triad protein as the active signaling form of Fhit. Proc Natl Acad Sci USA 1998, 95:5484-5489.
34. Pace H.C., Brenner C. The nitrilase superfamily: classification, structure and function. Genome Biol 2001, 2. REVIEWS0001.
35. Pace H.C., Hodawadekar S.C., Draganescu A., Huang J., Bieganowski P., Pekarsky Y., et al. Crystal structure of the worm NitFhit Rosetta Stone protein reveals a Nit tetramer binding two Fhit dimers. Curr Biol 2000, 10:907-917.
36. Pekarsky Y., Campiglio M., Siprashvili Z., Druck T., Sedkov Y., Tillib S., et al. Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans. Proc Natl Acad Sci USA 1998, 95:8744-8749.
37. Pichiorri F., Ishii H., Okumura H., Trapasso F., Wang Y., Huebner K. Molecular parameters of genome instability: roles of fragile genes at common fragile sites. J Cell Biochem 2008, 104:1525-1533.
38. Pichiorri F., Okumura H., Nakamura T., Garrison P.N., Gasparini P., Suh S.S., et al. Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions. J Biol Chem 2009, 284:1040-1049.
39. Reynolds J.J., El-Khamisy S.F., Caldecott K.W. Short-patch single-strand break repair in ataxia oculomotor apraxia-1. Biochem Soc Trans 2009, 37:577-581.
40. Reynolds J.J., El-Khamisy S.F., Katyal S., Clements P., McKinnon P.J., Caldecott K.W. Defective DNA ligation during short-patch single-strand break repair in ataxia oculomotor apraxia 1. Mol Cell Biol 2009, 29:1354-1362.
41. Saldivar J.C., Shibata H., Huebner K. Pathology and biology associated with the fragile FHIT gene and gene product. J Cell Biochem 2010, 109:858-865.
42. Semba S., Han S.Y., Qin H.R., McCorkell K.A., Iliopoulos D., Pekarsky Y., et al. Biological functions of mammalian Nit1, the counterpart of the invertebrate NitFhit Rosetta stone protein, a possible tumor suppressor. J Biol Chem 2006, 281:28244-28253.
43. Shi Y., Zou M., Farid N.R., Paterson M.C. Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9. Biochem J 2000, 352:443-448.
44. Siprashvili Z., Sozzi G., Barnes L.D., McCue P., Robinson A.K., Eryomin V., et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 1997, 94:13771-13776.
45. Sun J., Okumura H., Yearsley M., Frankel W., Fong L.Y., Druck T., et al. Nit1 and Fhit tumor suppressor activities are additive. J Cell Biochem 2009, 107:1097-1106.
46. Trapasso F., Krakowiak A., Cesari R., Arkles J., Yendamuri S., Ishii H., et al. Designed FHIT alleles established that Fhit-induced apoptosis in cancer cells is limited by substrate-binding. Proc Natl Acad Sci USA 2003, 100:1592-1597.
47. Trapasso F., Pichiorri F., Gasparo M., Palumbo T., Aqeilan R.I., Gaudio E., et al. Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis. J Biol Chem 2008, 283:13736-13744.
48. Weiske J., Huber O. The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF-beta-catenin-mediated transcription. J Cell Sci 2005, 118:3117-3129.
49. Weiske J., Albring K.F., Huber O. The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity. Proc Natl Acad Sci USA 2007, 104:20344-20349.
50. Zanesi N., Fidanza V., Fong L.Y., Mancini R., Druck T., Valtieri M., et al. The tumor spectrum in FHIT-deficient mice. Proc Natl Acad Sci USA 2001, 98:10250-10255.